These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 25527055

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
    Cwikla JB, Nasierowska-Guttmejer A, Jeziorski KG, Cichocki A, Zgliczynski W, Stepień K, Seklecka N, Durlik M, Malkowski B, Walecki J.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
    [Abstract] [Full Text] [Related]

  • 25. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
    Faggiano A, Modica R, Lo Calzo F, Camera L, Napolitano V, Altieri B, de Cicco F, Bottiglieri F, Sesti F, Badalamenti G, Isidori AM, Colao A.
    J Clin Endocrinol Metab; 2020 Jan 01; 105(1):. PubMed ID: 31586182
    [Abstract] [Full Text] [Related]

  • 26. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
    Dʼsouza SL, Elmunzer BJ, Scheiman JM.
    J Clin Gastroenterol; 2014 Jan 01; 48(5):458-61. PubMed ID: 24356459
    [Abstract] [Full Text] [Related]

  • 27. Linear-array EUS improves detection of pancreatic lesions in high-risk individuals: a randomized tandem study.
    Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, Farrell JJ, Canto MI.
    Gastrointest Endosc; 2015 Nov 01; 82(5):812-8. PubMed ID: 25930097
    [Abstract] [Full Text] [Related]

  • 28. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
    Ergul N, Gundogan C, Tozlu M, Toprak H, Kadıoglu H, Aydin M, Cermik TF.
    Rev Esp Med Nucl Imagen Mol; 2014 Nov 01; 33(3):159-64. PubMed ID: 24140024
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients.
    de Laat JM, Pieterman CR, Weijmans M, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD.
    J Clin Endocrinol Metab; 2013 Oct 01; 98(10):4143-51. PubMed ID: 23956349
    [Abstract] [Full Text] [Related]

  • 31. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
    Kappelle WF, Valk GD, Leenders M, Moons LM, Bogte A, Siersema PD, Vleggaar FP.
    Endoscopy; 2017 Jan 01; 49(1):27-34. PubMed ID: 27975336
    [Abstract] [Full Text] [Related]

  • 32. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
    Qiu W, Christakis I, Silva A, Bassett RL, Cao L, Meng QH, Gardner Grubbs E, Zhao H, Yao JC, Lee JE, Perrier ND.
    Clin Endocrinol (Oxf); 2016 Sep 01; 85(3):400-7. PubMed ID: 27256431
    [Abstract] [Full Text] [Related]

  • 33. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
    Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI.
    Gastrointest Endosc; 2008 Aug 01; 68(2):237-42; quiz 334, 335. PubMed ID: 18423464
    [Abstract] [Full Text] [Related]

  • 34. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
    Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ, Dutch research group on pancreatic cancer surveillance in high-risk individuals.
    Gut; 2016 Sep 01; 65(9):1505-13. PubMed ID: 25986944
    [Abstract] [Full Text] [Related]

  • 35. Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study Group.
    Klein Haneveld MJ, van Treijen MJC, Pieterman CRC, Dekkers OM, van de Ven A, de Herder WW, Zandee WT, Drent ML, Bisschop PH, Havekes B, Vriens MR, Verrijn Stuart AA, Valk GD, van Leeuwaarde RS.
    J Clin Endocrinol Metab; 2021 Nov 19; 106(12):3515-3525. PubMed ID: 34333645
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR, Schreinemakers JM, Koppeschaar HP, Vriens MR, Rinkes IH, Zonnenberg BA, van der Luijt RB, Valk GD.
    Clin Endocrinol (Oxf); 2009 Apr 19; 70(4):575-81. PubMed ID: 18616711
    [Abstract] [Full Text] [Related]

  • 38. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
    Krishna SG, Bhattacharya A, Ross WA, Ladha H, Porter K, Bhutani MS, Lee JH.
    J Gastroenterol Hepatol; 2015 Oct 19; 30(10):1552-60. PubMed ID: 25867963
    [Abstract] [Full Text] [Related]

  • 39. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK, Halperin R, Percik R, Uri I, Halpern N, Shlomai G, Laish I, Tirosh A, Tirosh A.
    Horm Metab Res; 2021 May 19; 53(5):319-325. PubMed ID: 33878789
    [Abstract] [Full Text] [Related]

  • 40. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
    Chiloiro S, Lanza F, Bianchi A, Schinzari G, Brizi MG, Giampietro A, Rufini V, Inzani F, Giordano A, Rindi G, Pontecorvi A, De Marinis L.
    Endocrine; 2018 May 19; 60(2):362-367. PubMed ID: 28567607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.